BIOHLDG (0179) - Bioalpha plans new plant
Ace Market candidate expects to raise RM20mil from listing
BANGI: Bioalpha Holdings Bhd, en route to listing on the Ace Market of Bursa Malaysia early next month, is expected to raise about RM20mil in proceeds that will mainly be utilised as working capital, for the construction of a new factory, research and development as well as e-payment of borrowing.
Managing director cum chief executive officer William Hon Kok Tian is currently the single largest shareholder of the integrated health supplement company.
Other two major shareholders are Malaysia Technology Development Corp (MTDC) and Perbadanan Nasional Bhd. Both have been with the company since 2008 and 2014 respectively.
Bioalpha is principally involved in the manufacturing and sales of semi-finished and finished health supplement products as an original design manufacturer (ODM) as well as under its house brands.
The company, which is launching its prospectus today, is expected to maintain its dividend policy of 30% of its after-tax profit.
Bioalpha’s listing is expected to attract investor interest as the counter will be involved in full-value chain – from farming to retailing – of the lucrative health supplement products.
The company posted net profit of RM6.3mil on the back of RM24.5mil revenue for the year ended Sept 30, 2013.
“Our core business and strength lie on our ODM segment serving multinational clients with health products available in local pharmacies.
“We have our own farms in Desaru and Pasir Raja planted with local herbs such as roselle, kacip fatimah and misai kucing. Additionally, we have two factories in Semenyih and Bangi and a flagship Lifesprings pharmacy in Solaris Mon’t Kiara.
“We plan to add more outlets throughout the year and currently we are among eight anchor companies chosen by Pemandu to do clinical trials to substantiate two herb-based medicine products for diabetes and lessen menopause symptoms
“Health supplements industry is a growing and recession-proof industry and we are targeting to serve more of the middle-income consumer market in line with the improving socio-economic demographic of the country, ” he told StarBiz.
Hon pointed out that Bioalpha also managed to “clone” expensive herbs such as quadriceps through its patented fermentation process that lowered lthe cost of importing of the once a year harvested plant without compromising its original health benefits.
“We also have three of our own in-house brandnames which feature an array of more than 100 products
“Our farms also supply raw materials to other health supplement manufacturers,” he said.
http://www.thestar.com.my
Ace Market candidate expects to raise RM20mil from listing
BANGI: Bioalpha Holdings Bhd, en route to listing on the Ace Market of Bursa Malaysia early next month, is expected to raise about RM20mil in proceeds that will mainly be utilised as working capital, for the construction of a new factory, research and development as well as e-payment of borrowing.
Managing director cum chief executive officer William Hon Kok Tian is currently the single largest shareholder of the integrated health supplement company.
Other two major shareholders are Malaysia Technology Development Corp (MTDC) and Perbadanan Nasional Bhd. Both have been with the company since 2008 and 2014 respectively.
Bioalpha is principally involved in the manufacturing and sales of semi-finished and finished health supplement products as an original design manufacturer (ODM) as well as under its house brands.
The company, which is launching its prospectus today, is expected to maintain its dividend policy of 30% of its after-tax profit.
Bioalpha’s listing is expected to attract investor interest as the counter will be involved in full-value chain – from farming to retailing – of the lucrative health supplement products.
The company posted net profit of RM6.3mil on the back of RM24.5mil revenue for the year ended Sept 30, 2013.
“Our core business and strength lie on our ODM segment serving multinational clients with health products available in local pharmacies.
“We have our own farms in Desaru and Pasir Raja planted with local herbs such as roselle, kacip fatimah and misai kucing. Additionally, we have two factories in Semenyih and Bangi and a flagship Lifesprings pharmacy in Solaris Mon’t Kiara.
“We plan to add more outlets throughout the year and currently we are among eight anchor companies chosen by Pemandu to do clinical trials to substantiate two herb-based medicine products for diabetes and lessen menopause symptoms
“Health supplements industry is a growing and recession-proof industry and we are targeting to serve more of the middle-income consumer market in line with the improving socio-economic demographic of the country, ” he told StarBiz.
Hon pointed out that Bioalpha also managed to “clone” expensive herbs such as quadriceps through its patented fermentation process that lowered lthe cost of importing of the once a year harvested plant without compromising its original health benefits.
“We also have three of our own in-house brandnames which feature an array of more than 100 products
“Our farms also supply raw materials to other health supplement manufacturers,” he said.
http://www.thestar.com.my
